Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Tipo de documento
País de afiliação
Intervalo de ano de publicação
2.
ACS Appl Mater Interfaces ; 10(15): 12351-12363, 2018 Apr 18.
Artigo em Inglês | MEDLINE | ID: mdl-29569435

RESUMO

Multidrug resistance (MDR) is thought to be the major obstacle leading to the failure of paclitaxel (PTX) chemotherapy. To solve this problem, a glucose transporter-mediated and matrix metalloproteinase 2 (MMP2)-triggered mitochondrion-targeting conjugate [glucose-polyethylene glycol (PEG)-peptide-triphenylphosponium-polyamidoamine (PAMAM)-PTX] composed of a PAMAM dendrimer and enzymatic detachable glucose-PEG was constructed for mitochondrial delivery of PTX. The conjugate was characterized by a 30 nm sphere particle, MMP2-sensitive PEG outer layer detachment from PAMAM, and glutathione (GSH)-sensitive PTX release. It showed higher cellular uptake both in glucose transporter 1 (GLUT1) overexpressing MCF-7/MDR monolayer cell (2D) and multicellular tumor spheroids (3D). The subcellular location study showed that it could specifically accumulate in the mitochondria. Moreover, it exhibited higher cytotoxicity against MCF-7/MDR cells, which significantly reverse the MDR of MCF-7/MDR cells. The MDR reverse might be caused by reducing the ATP content through destroying the mitochondrial membrane as well as by down-regulating P-gp expression. In vivo imaging and tissue distribution indicated more conjugate accumulated in the tumor of the tumor-bearing mice model. Consequently, the conjugate showed better tumor inhibition rate and lower body weight loss, which demonstrated that it possessed high efficiency and low toxicity. This study provides glucose-mediated GLUT targeting, MMP2-responsive PEG detachment, triphenylphosponium-mediated mitochondria targeting, and a GSH-sensitive intracellular drug release conjugate that has the potential to be exploited for overcoming MDR of PTX.


Assuntos
Resistência a Múltiplos Medicamentos , Animais , Linhagem Celular Tumoral , Resistencia a Medicamentos Antineoplásicos , Transportador de Glucose Tipo 1 , Humanos , Células MCF-7 , Metaloproteinase 2 da Matriz , Camundongos , Micelas , Oxirredução , Paclitaxel , Polietilenoglicóis
3.
Adv Mater ; 24(14): 1884-8, 2012 Apr 10.
Artigo em Inglês | MEDLINE | ID: mdl-22407518

RESUMO

Light-weight PEDOT-Pt/Ti mesh and Ti/TiO(2) foil electrodes are prepared. Owing to the PEDOT-Pt/Ti photocathode's high transparency, good electrocatalytic activity, and low resistance; the Ti/TiO(2) anode's large specific area and high conductivity, a light-weight backside illuminated large-area (100 cm(2) ) dye-sensitized solar cell achieves an energy conversion efficiency of 6.69% under an outdoors sunlight irradiation of 55 mW cm(-2) .


Assuntos
Corantes/química , Energia Solar , Titânio/química , Compostos Bicíclicos Heterocíclicos com Pontes/química , Catálise , Técnicas Eletroquímicas , Eletrodos , Platina/química , Polímeros/química
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA